Heyholder
‹ Activism Filings

ARIBIOLAB Agrees to dispose of KRW 1.0 billion face value of 7th CBs for KRW 1.1 billion

ARIBIOLAB· Material Event Report

AI summary · Not investment advice

ARIBIOLAB agreed to dispose of KRW 1.0 billion face value of its 7th convertible bonds, to be bought back via a call option, to a corporate buyer for KRW 1.1 billion. The balance is due April 16, 2028.

Sale amount

KRW 1.1 billion

0.90% of total shares if converted; agreed with the buyer

Key facts

% of total shares
0.90%
Total face value
KRW 7.0 billion
Conversion price per share
KRW 3,790
Convertible shares
263,852 shares
Conversion period
Oct 16, 2027 – Sep 16, 2029
Buyer
A corporate buyerFace value KRW 1.0 billion
Sale proceeds receipt date
Oct 16, 2026Down payment of KRW 100.0 million; balance due 2028.04.16
Bond type
7th unsecured private convertible bonds
Bond issue date
Oct 16, 2026
Maturity date
Oct 16, 2029

Commentary

AI commentary · Not investment advice

What happened

ARIBIOLAB agreed to dispose of KRW 1.0 billion face value of its 7th convertible bonds (bonds that can later be turned into shares) to a corporate buyer. The price is KRW 1.1 billion. The company does not hold these bonds yet. It will first acquire them by using its call option (a right to take the bonds back early), then pass part of them to the buyer. The stated purpose is working capital.

In the company's terms

The bond issue totals KRW 7.0 billion. If the KRW 1.0 billion portion is fully converted at KRW 3,790 per share, 263,852 shares would be created. That equals 0.90% of total shares.

What changes for shareholders

The company receives a down payment of KRW 100.0 million on signing. It will receive the balance on April 16, 2028, and transfer the bonds to the buyer that day. The bonds can be converted from October 16, 2027 to September 16, 2029.

Earlier Material Event Report filings from this company

Filings of the same type
FiledTitleKey figure · Note
26.11.04Material Event ReportKRW 10.0 billion · 84.32% of equity

Comments

No comments yet

Comments from shareholders will appear here.